Literature DB >> 26439613

Paternal history of diabetes mellitus and hypertension affects the prevalence and phenotype of PCOS.

Chen Cheng1,2,3, Haolin Zhang1,2,3, Yue Zhao1,2,3, Rong Li4,5,6, Jie Qiao1,2,3.   

Abstract

PURPOSE: The purpose of the present study is to determine if paternal or maternal history of diabetes mellitus (DM) and hypertension (HT) contributes to the prevalence and phenotype of polycystic ovary syndrome (PCOS).
METHODS: We performed an epidemiologic study about PCOS from four districts in Beijing, China, between 2008 and 2009. Parental histories of DM and HT were collected, and the basic characteristics and serum indices of 123 PCOS patients and 718 non-PCOS controls were tested.
RESULTS: The prevalence of a parental history of DM and HT was significantly higher in PCOS patients than non-PCOS women (17.1 % vs. 9.2 % and 42.3 % vs. 26.0 %, P < 0.05, respectively). When paternal history was separated from maternal history, only a paternal history of DM and HT reached statistical significance between PCOS and non-PCOS patients (odds ratio (OR) = 3.42, 95 % confidence interval (CI) = 1.69-6.91; OR = 2.50, 95 % CI = 1.58-3.93, respectively). A paternal history of both DM and HT was significantly associated with sex hormone-binding globulin, fasting plasma glucose, and fasting insulin levels, the free androgen index, and the homeostatic model assessment-insulin resistance in PCOS patients (P < 0.05 for all). There was no independent association between maternal history and the clinical or biochemical phenotype of PCOS.
CONCLUSIONS: PCOS patients with a positive paternal history of both DM and HT have an adverse endocrine and metabolic profile. A paternal history of DM and HT poses a risk to PCOS.

Entities:  

Keywords:  Diabetes mellitus; Hypertension; Paternal history; Phenotype; Polycystic ovary syndrome (PCOS)

Mesh:

Year:  2015        PMID: 26439613      PMCID: PMC4681733          DOI: 10.1007/s10815-015-0587-y

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  32 in total

1.  Persistence pays off for PCOS gene prospectors.

Authors:  Jerome F Strauss; Jan M McAllister; Margrit Urbanek
Journal:  J Clin Endocrinol Metab       Date:  2012-07       Impact factor: 5.958

2.  Familial clustering in the polycystic ovarian syndrome.

Authors:  O Lunde; P Magnus; L Sandvik; S Høglo
Journal:  Gynecol Obstet Invest       Date:  1989       Impact factor: 2.031

3.  Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome.

Authors:  S M Veltman-Verhulst; T W van Haeften; M J C Eijkemans; H W de Valk; B C J M Fauser; A J Goverde
Journal:  Hum Reprod       Date:  2010-10-13       Impact factor: 6.918

4.  Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome.

Authors:  Yongyong Shi; Han Zhao; Yuhua Shi; Yunxia Cao; Dongzi Yang; Zhiqiang Li; Bo Zhang; Xiaoyan Liang; Tao Li; Jianhua Chen; Jiawei Shen; Junzhao Zhao; Li You; Xuan Gao; Dongyi Zhu; Xiaoming Zhao; Ying Yan; Yingying Qin; Wenjin Li; Junhao Yan; Qingzhong Wang; Junli Zhao; Ling Geng; Jinlong Ma; Yueran Zhao; Guang He; Aiping Zhang; Shuhua Zou; Aijun Yang; Jiayin Liu; Weidong Li; Baojie Li; Chunling Wan; Ying Qin; Juanzi Shi; Jing Yang; Hong Jiang; Jin-e Xu; Xiujuan Qi; Yun Sun; Yajie Zhang; Cuifang Hao; Xiuqing Ju; Dongni Zhao; Chun-e Ren; Xiuqing Li; Wei Zhang; Yiwen Zhang; Jiangtao Zhang; Di Wu; Changming Zhang; Lin He; Zi-Jiang Chen
Journal:  Nat Genet       Date:  2012-08-12       Impact factor: 38.330

Review 5.  Polycystic ovary syndrome (PCOS).

Authors:  D Dewailly; S Hieronimus; P Mirakian; J-N Hugues
Journal:  Ann Endocrinol (Paris)       Date:  2010-01-22       Impact factor: 2.478

6.  Endometrial thickness, uterine, and ovarian ultrasonographic features in adolescents with polycystic ovarian syndrome.

Authors:  Bina Shah; Lauren Parnell; Sarah Milla; Marion Kessler; Raphael David
Journal:  J Pediatr Adolesc Gynecol       Date:  2009-09-03       Impact factor: 1.814

7.  Endometrial thickness measurement throughout a menstrual cycle in non-obese infertile patients with polycystic ovary syndrome.

Authors:  Ozlem Gun Eryilmaz; Esma Sarikaya; Cavidan Gulerman; Serra Akar; Nedim Cicek
Journal:  Arch Gynecol Obstet       Date:  2012-08-04       Impact factor: 2.344

8.  Genome-wide association study identifies GYS2 as a novel genetic factor for polycystic ovary syndrome through obesity-related condition.

Authors:  Joo-Yeon Hwang; Eun-Ju Lee; Min Jin Go; Yeon-Ah Sung; Hye Jin Lee; Soo Heon Kwak; Hak C Jang; Kyung Soo Park; Hye-Ja Lee; Han Byul Jang; Jihyun Song; Kyung-Hee Park; Hyung-Lae Kim; Myeong-Chan Cho; Jong-Young Lee
Journal:  J Hum Genet       Date:  2012-09-06       Impact factor: 3.172

9.  Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.

Authors:  Bart C J M Fauser; Basil C Tarlatzis; Robert W Rebar; Richard S Legro; Adam H Balen; Roger Lobo; Enrico Carmina; Jeffrey Chang; Bulent O Yildiz; Joop S E Laven; Jacky Boivin; Felice Petraglia; C N Wijeyeratne; Robert J Norman; Andrea Dunaif; Stephen Franks; Robert A Wild; Daniel Dumesic; Kurt Barnhart
Journal:  Fertil Steril       Date:  2011-12-06       Impact factor: 7.329

10.  FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome.

Authors:  Kathryn G Ewens; Michelle R Jones; Wendy Ankener; Douglas R Stewart; Margrit Urbanek; Andrea Dunaif; Richard S Legro; Angela Chua; Ricardo Azziz; Richard S Spielman; Mark O Goodarzi; Jerome F Strauss
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

View more
  3 in total

1.  Morning blood pressure surge and its relation to insulin resistance in patients of reproductive age with polycystic ovary syndrome.

Authors:  Hasan Kadi; Eyup Avci; Akin Usta; Abdullah Orhan Demirtaş
Journal:  Reprod Biol Endocrinol       Date:  2018-08-09       Impact factor: 5.211

2.  Family history of menstrual irregularity or diabetes mellitus enhances the susceptibility to polycystic ovary syndrome among subjects harboring rs7903146 genetic variant of TCF7L2.

Authors:  Rabiya Rashid; Idrees A Shah; Mir M Asrar; Meena Godha; Bashir A Ganai; Mohd Ashraf Ganie
Journal:  J Diabetes Metab Disord       Date:  2022-05-17

3.  Transcription factor‑microRNA synergistic regulatory network revealing the mechanism of polycystic ovary syndrome.

Authors:  Hai-Ying Liu; Yu-Ling Huang; Jian-Qiao Liu; Qing Huang
Journal:  Mol Med Rep       Date:  2016-03-21       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.